Allied Market Research published a report, titled, “Acute Ischemic Stroke Diagnosis Market by Technology (Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography and Others), End User (Hospitals and Clinics, Ambulatory Surgery Centers, Diagnostic Laboratories and Imaging Centers and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the acute ischemic stroke diagnosis market was valued at $2.1 billion in 2023, and is estimated to reach $3.6 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐ ๐๐๐ฎ๐ญ๐ ๐๐ฌ๐๐ก๐๐ฆ๐ข๐ ๐๐ญ๐ซ๐จ๐ค๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ
- Koninklijke Philips N.V.
- GE Healthcare
- Canon Inc.
- Simens
- Terumo Corporation
- Stryker
- Fujifilm Holdings Corporation
- Samsung Electronics Co. Ltd
- Hoffmann-La Roche AG
- Boehringer Ingelheim
๐๐ซ๐ข๐ฆ๐ ๐๐๐ญ๐๐ซ๐ฆ๐ข๐ง๐๐ง๐ญ๐ฌ ๐จ๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก
Increase in prevalence of acute ischemic stroke, rise in awareness about the importance of early diagnosis, and government initiatives & funding are the major factors that drive the growth of the acute ischemic stroke diagnosis market. However, the high cost of acute ischemic stroke diagnostic devices restricts market growth. Moreover, growth opportunities in emerging markets are expected to boost the expansion of the global acute ischemic stroke diagnosis market.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/A323961
The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining competitive edge in the market.
๐๐๐ฎ๐ญ๐ ๐๐ฌ๐๐ก๐๐ฆ๐ข๐ ๐๐ญ๐ซ๐จ๐ค๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง
Based on technology, the clinical biochemistry segment held the highest market share in 2022, accounting for one third of the U.S. companion animal diagnostic market revenue, owing to the ability of clinical biochemistry technology to test for wide array of diseases in companion animals.
Based on applications, the clinical pathology segment held the highest market share in 2022, accounting for more than one third of the U.S. companion animal diagnostic market revenue. This is attributed to the rise in incidence of chronic diseases such as diabetes, cancer and other.
Based on animal type, the dog segment held the highest market share in 2022, accounting for nearly half of the U.S. companion animal diagnostic market revenue. This is attributed to high adoption of dogs at companion animal in U.S.
Based on end user, the diagnostics labs segment held the highest market share in 2022, accounting for more than one third of the U.S. companion animal diagnostic market revenue. This is attributed to high adoption of diagnostic products in the diagnostic labs for detection of diseases in companion animals.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/A323961
๐๐ฎ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฎ ๐๐ง๐ฌ๐ฐ๐๐ซ ๐ญ๐จ ๐๐๐ฅ๐จ๐ฐ ๐๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ญ๐๐ข๐ฅ๐ฌ:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
